Details for New Drug Application (NDA): 020816
✉ Email this page to a colleague
The generic ingredient in AZOPT is brinzolamide. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the brinzolamide profile page.
Summary for 020816
Tradename: | AZOPT |
Applicant: | Sandoz |
Ingredient: | brinzolamide |
Patents: | 0 |
Pharmacology for NDA: 020816
Mechanism of Action | Carbonic Anhydrase Inhibitors |
Suppliers and Packaging for NDA: 020816
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AZOPT | brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 020816 | NDA | Novartis Pharmaceuticals Corporation | 0078-0722 | 0078-0722-10 | 1 BOTTLE in 1 CARTON (0078-0722-10) / 10 mL in 1 BOTTLE |
AZOPT | brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 020816 | NDA | Novartis Pharmaceuticals Corporation | 0078-0722 | 0078-0722-15 | 1 BOTTLE in 1 CARTON (0078-0722-15) / 15 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION/DROPS;OPHTHALMIC | Strength | 1% | ||||
Approval Date: | Apr 1, 1998 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020816
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | AZOPT | brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 020816-001 | Apr 1, 1998 | ⤷ Subscribe | ⤷ Subscribe |
Sandoz | AZOPT | brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 020816-001 | Apr 1, 1998 | ⤷ Subscribe | ⤷ Subscribe |
Sandoz | AZOPT | brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 020816-001 | Apr 1, 1998 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription